Allspring Global Investments’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
PCM
NIM
FHA
AAM
1WA
RCM
Allspring Global Investments's HQL Position: Q2 2026 in Review
Allspring Global Investments increased its abrdn Life Sciences Investors (HQL) stake by 26% in Q2 2026, buying an estimated $1.64M and bringing the position to 455,124 shares worth $9.11M. The position accounts for 0.01% of the portfolio, ranked #742.
Allspring Global Investments first reported a position in HQL in Q4 2022 and has held it in 15 quarters since. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.
- Allspring Global Investments held 455,124 shares of abrdn Life Sciences Investors worth $9.11M as of Q2 2026.
- Allspring Global Investments bought 92,589 abrdn Life Sciences Investors shares in Q2 2026, an estimated $1.64M.
- abrdn Life Sciences Investors made up 0.01% of Allspring Global Investments's portfolio in Q2 2026, its #742 holding.
- Allspring Global Investments first reported a position in abrdn Life Sciences Investors in Q4 2022 and has held it in 15 quarters since.
- 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.
Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.